 |
|
|
 |
 |
 |
 |
Kinexum serves as an incubator for advancing innovative ideas, healthcare products, and services to create value.
|
 |
|
|
 |
 |
 |
 |
 |
|
|
Connecting Science, Medicine, and Industry
Kinexum serves the pharmaceutical, biotechnology, and other health products and services industries. We provide sophisticated and highly informed guidance for health product discovery, development and clinical integration including regulatory, funding, reimbursement, and marketing strategies. Our organizational values reflect our belief that it is not just what we do, but how we do it, that is important.
our purpose and values >>
Kinexum's interests and capabilities span pharmaceuticals, biologics, medical devices, diagnostics, and software systems. Kinexum applies first hand experience and expertise to create solutions for complex challenges.
our leadership team >>
We provide broad capabilities and experience to catalyze strategic thinking, productivity, and transformation. Our services and capabilities span the product life cycle:
- Scientific discovery to proof of concept
- Proof of concept to regulatory submission and market assessment
- Product development finalization to sales and marketing integration
We assist health product innovators and companies with strategy and transition planning to effectively manage through the phases of healthcare product development. From early product design and development to the launch stage, Kinexum supports the needs for health product development.
our services >>
Copyright © 2004 Kinexum LLC | terms of use | privacy
|
|
|
|
|
|
|
|
|
|
|
Dr. G. Alexander Fleming, Kinexum CEO, to speak at Metabolic Summit November
1-2 in San Diego, California. Generating β-cells in TI and T2
Diabetes
Mellitus—a Promising Therapeutic Target and Plenary Lecture: The
Future Regulatory Environment for Metabolic Drugs—Sorting through
the Good, the Bad, and the Ugly. For more information and to register – [Link]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dr. G. Alexander Fleming, Kinexum CEO, to speak at education conference November 29-30 in Alexandria, Virginia. Pipeline to Product – Navigating the FDA Approval Process. For more information and to register – [Link]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As an FDA leader for over a decade, Kinexum CEO Zan Fleming led efforts to re-engineer the organization, shape regulatory policy, and improve the morale and capability of the professional staff.
more >>
|
|
|
|
|
|
|
|
|
|
